WuXi AppTec Co., Ltd.
603259
주식 순위
#465
WuXi AppTec Co., Ltd., an investment holding company, provides research and... WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions which support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides laboratory testing services, such as toxicology, DMPK, and bioanalytical services; clinical contract research organization services, including Phase I to Phase IV clinical development services, and bioequivalence for products including pharmaceuticals and biologics; and site management organization, patient recruitment, site start-up, and academic research organization. In addition, it offers services for biology; CDRMO platform for small molecules, oligonucleotides, and peptides; drug research and development testing; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People’s Republic of China.
주가
$21.23
시가총액
$52.51B
변동 (1일)
1.52%
변동 (1년)
41.53%
국가
CN
거래 WuXi AppTec Co., Ltd. (603259)
카테고리
Healthcare
의 시가총액 WuXi AppTec Co., Ltd.(603259)
시가총액: $52.51B
October 2026 기준으로 WuXi AppTec Co., Ltd.의 시가총액은 $52.51B입니다. 이는 당사 데이터에 따르면 WuXi AppTec Co., Ltd.이 세계에서 465th번째로 가치 있는 기업임을 의미합니다. 시가총액은 상장된 회사의 발행 주식 총 시장 가치를 의미하며, 일반적으로 회사의 가치를 측정하는 데 사용됩니다.
2020부터 2026까지 WuXi AppTec Co., Ltd.의 시가총액 기록
